SCHEMBL29872989

SCHEMBL29872989

COc1ccc(Cn2nc(OC(F)F)c3cc(OC4CCC(N)CC4)cnc32)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BUB1 O43683 1/20 0.40
▸ CNR2 P34972 2/20 0.36
▸ CNR1 P21554 1/20 0.36
▸ AXL P30530 3/20 0.36
▸ MERTK Q12866 3/20 0.36
▸ TYRO3 Q06418 2/20 0.36
▸ PDE5A O76074 1/20 0.35
▸ PDE1B Q01064 7/20 0.34
▸ ALDH1A1 P00352 3/20 0.34
▸ LMNA P02545 2/20 0.34
▸ MAPT P10636 2/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ PDE4A P27815 1/20 0.34
▸ PDE4B Q07343 1/20 0.34
▸ PDE4C Q08493 1/20 0.34
▸ PDE4D Q08499 1/20 0.34
▸ PDGFRA P16234 1/20 0.34
▸ CCNE1 P24864 1/20 0.34
▸ CDK2 P24941 1/20 0.34
▸ IRAK1 P51617 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29873410 0.84 PDE1B (0.43) CNR2CNR1AXLMERTKTYRO3
SCHEMBL29873199 0.83 CACNA1B (0.39) BUB1CNR2CNR1ALDH1A1PDE4A
SCHEMBL29872618 0.82 CNR1 (0.39) CNR2CNR1PDE5APDE1BALDH1A1
SCHEMBL23069175 0.82 CNR1 (0.43) CNR2CNR1PDE5APDE1BALDH1A1
SCHEMBL29873478 0.82 CNR1 (0.43) CNR2CNR1PDE5APDE1BALDH1A1
SCHEMBL29872865 0.79 PDE1B (0.50) CNR2CNR1PDE5APDE1BALDH1A1
SCHEMBL29872986 0.79 CNR2 (0.45) CNR2CNR1PDE5APDE1BALDH1A1
SCHEMBL23069164 0.79 PDE1B (0.50) CNR2CNR1PDE5APDE1BALDH1A1
SCHEMBL29872711 0.77 ACACB (0.33) BUB1AXLMERTKPDE5APDE1B
SCHEMBL29873129 0.75 MAPT (0.46) CNR2CNR1PDE5ALMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220306640-A1 HYDANTOIN DERIVATIVE ONO PHARMACEUTICAL CO., LTD. (JP) 2022-09-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220306640-A1 HYDANTOIN DERIVATIVE DDR1, DDR2, DDRGK1 BUB1 548/4885CNR2 3824/4885CNR1 2761/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback